Milestone Scientific's CompuFlo Epidural System Now Available at The Painless Center in Tenafly, New Jersey

Milestone Scientific has initiated commercial sales of its CompuFlo Epidural System at The Painless Center in Tenafly, New Jersey. The system utilizes DPS Dynamic Pressure Sensing technology, which provides real-time feedback to accurately identify the epidural space. The technology has been shown to significantly reduce complications and improve the success rate of epidural procedures. Milestone Scientific continues to advance its strategic sales and marketing initiatives to broaden awareness and accelerate adoption of CompuFlo throughout the U.S. and international markets.

Milestone Scientific Inc. (NYSE: MLSS) has announced the commercial launch of its CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey. The system leverages the company's proprietary DPS Dynamic Pressure Sensing® technology, providing real-time feedback for accurate epidural space identification. This deployment is part of Milestone Scientific's broader strategy to expand the adoption of CompuFlo across U.S. and international markets.

The CompuFlo system addresses a critical clinical need in epidural procedures through its proprietary DPS Dynamic Pressure Sensing® technology. By providing objective, real-time feedback during needle placement, the technology helps practitioners accurately identify the epidural space – a significant improvement over the subjective "loss of resistance" technique traditionally used. Clinical studies validate the system's ability to reduce false positives and minimize complications, key selling points for risk-averse medical institutions.

This deployment follows a series of successful CompuFlo deployments across leading institutions, suggesting growing commercial momentum. For Milestone Scientific, each new customer installation establishes a recurring revenue stream through the disposable components required for each procedure. The company's strategic focus on interventional pain represents a targeted approach to market penetration, prioritizing specialized practices where precision injection technologies deliver clear clinical value.

While a single site deployment doesn't dramatically alter the company's revenue trajectory, it demonstrates continued commercial execution and builds credibility for their ongoing sales and marketing initiatives in both domestic and international markets.

References:
[1] https://www.stocktitan.net/news/MLSS/milestone-scientific-commences-sales-of-compu-flo-epidural-system-at-6il6a264inyo.html